Univariate analysis of the clinicopathologic characteristics revealed that tumor size (> 2 cm) and lymph node involvement were significantly related to poorer RFS and OS, while receiving adjuvant chemotherapy and T-bet+ tumors were significantly related to better OS (Table 2a). This evidence concerns the gene TBX21 and neoplasm.